SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?


To: Anthony@Pacific who wrote (52582)3/6/2000 1:51:00 PM
From: Street Hawk  Respond to of 122087
 
Phase I/II clinical trials, initially evaluating final formulation components in patients with refractory metastatic pancreatic and colorectal cancer, are
expected to initiate in the first half of 2001.


From the www.neorx.com website.

They haven't even gotten started in the Phase I/II trials!
Its all speculation and hype.



To: Anthony@Pacific who wrote (52582)3/6/2000 5:47:00 PM
From: Brandon Buttons  Read Replies (1) | Respond to of 122087
 
Anthony,

<<Its not like IMCL which is 6 to 12 months awayfrom real FDA approval!!!!!!!!!!!!!!!!>>

Do you really think they are that far away? With the big price movement almost every day --- something is going on.
Can news be leaking from the test or have the institutions radar started to pick up on something?

Brandon